Balance Sheet Data

FibroGen Inc (FGEN)

$ 18.57
-0.24 (-1.28%)

Year
A/P
2013
Actual
2014
Actual
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Total Cash 122.81179.82181.17253.18735.72621.40533.76686.54491.69557.75632.69717.69814.11
Total Cash (%)
Account Receivables 17.5013.4515.4010.458.4563.6828.4641.8828.1831.9636.2641.1346.66
Account Receivables (%)
Inventories ------6.8916.5312.0613.6815.5217.6019.97
Inventories (%)
Accounts Payable 1.074.556.526.225.519.146.0924.799.1310.3611.7513.3315.12
Accounts Payable (%)
Capital Expenditure -6.81-8.12-1.98-1.25-8.50-8.02-5.76-3.99-7.35-8.34-9.46-10.73-12.17
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.